RNA Aptamers that Differentiate Among HIV-1 Capsid Assembly States
区分 HIV-1 衣壳组装状态的 RNA 适体
基本信息
- 批准号:9303240
- 负责人:
- 金额:$ 23.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-24 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsBindingBinding SitesBioinformaticsBiologicalBiologyCapsidCapsid ProteinsCellsConeDefectDimerizationDissociationElementsEnzymesEquilibriumEventFullerenesFutureGenetic MaterialsHIVHIV-1HealthImmune responseIn VitroIntegration Host FactorsInvestigationLeadLife Cycle StagesLinkMediatingMethodsMutationNatural ImmunityNuclear ImportPeptide HydrolasesPharmaceutical PreparationsProcessProteinsPublic HealthRNAResearchReverse TranscriptionRoleSiteSolventsStructureSurfaceViralViral PathogenesisVirusVirus ReplicationWorkaptamerdimerexperimental studygag Gene Productsin vivosmall moleculestructural biologytoolvirus genetics
项目摘要
Project Summary
The mature HIV-1 capsid core has emerged as a key antiviral target because of its critical role in HIV infectivity
and the discovery of capsid-specific host restriction factors, such as TRIM5α and MX2. Recent work has
demonstrated that capsid does much more than simply house the viral genetic material and required
replication enzymes. It also participates in and may mediate several critical replication events,
including uncoating, initiation of reverse transcription, nuclear import, integration, and evasion of host immune
responses. For each of these processes to occur, a delicate balance between capsid stability and dissociation
must be maintained, demonstrating an intricate link between capsid and viral infectivity.
The mature capsid lattice is formed following protease-mediated cleavage of the Gag polyprotein. The basic
structural element of the mature lattice is a capsid protein (CA) hexamer, comprising a trimer of CA dimers.
The fullerene cone structure contains ~250 hexamers, along with 12 pentamers to facilitate closing. Mutations
that alter the relative stability of capsid protein (CA) assembly states (dimers, pentamers, hexamers, or the
assembled lattice) result in severe infectivity defects due to disruption of one or more replication events.
Replication can also be impacted through alteration of host factor binding. Notably, the specific roles of CA in
these events is not well understood, and it is unknown how the various CA assembly states contribute to
capsid function or interactions with host factors involved in replication. There are currently no tools available to
differentiate CA assembly states in vivo to assess their role during replication events. This project will
identify and characterize RNA aptamers that bind sites specific to the assembled hexamer lattice and
differentiate among CA assembly states by binding to unique solvent-exposed crevices that define
each independent CA assembly state. The proposed experiments capitalize on the research team's
expertise in poly-target aptamer selection, advances in post-selection bioinformatics analysis, intracellular
aptamer expression, HIV biology, and innate immunity. Importantly, the proposed approach could be widely
applicable to other viruses of importance to public health.
项目摘要
成熟的HIV-1衣壳核心由于其在HIV感染性中的关键作用而成为关键的抗病毒靶点
以及发现了衣壳蛋白特异性宿主限制因子,如TRIM 5 α和MX2。最近的工作已经
证明了衣壳不仅仅是简单地容纳病毒遗传物质,
复制酶它还参与并可能介导几个关键的复制事件,
包括去包被、启动逆转录、核输入、整合和逃避宿主免疫
应答对于这些过程中的每一个发生,衣壳稳定性和解离之间的微妙平衡
必须保持,证明了衣壳和病毒感染性之间的复杂联系。
成熟的衣壳晶格在蛋白酶介导的Gag多蛋白裂解后形成。基本
成熟晶格的结构元件是衣壳蛋白(CA)六聚体,其包含CA二聚体的三聚体。
富勒烯锥结构包含约250个六聚体,沿着有12个五聚体以便于闭合。突变
改变衣壳蛋白(CA)组装状态(二聚体、五聚体、六聚体或
组装的晶格)由于一个或多个复制事件的中断而导致严重的感染性缺陷。
复制也可以通过改变宿主因子结合来影响。值得注意的是,CA在以下方面的具体作用
对这些事件的理解还不很清楚,也不知道各种CA组装状态对
衣壳功能或与复制中涉及的宿主因子的相互作用。目前没有工具可用于
在体内区分CA组装状态以评估它们在复制事件期间的作用。该项目将
鉴定和表征RNA适体,所述RNA适体结合对组装的六聚体晶格特异的位点,
通过绑定到独特的溶剂暴露裂缝来区分CA组装状态,
每个独立的CA组件状态。拟议的实验利用了研究小组的
多靶适体选择的专业知识,选择后生物信息学分析的进展,细胞内
适体表达、HIV生物学和先天免疫。重要的是,拟议的方法可以广泛地
适用于对公共卫生有重要意义的其他病毒。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds.
GS-CA 化合物:涵盖多种领域的一流 HIV-1 衣壳抑制剂。
- DOI:10.3389/fmicb.2019.01227
- 发表时间:2019
- 期刊:
- 影响因子:5.2
- 作者:Singh,Kamal;Gallazzi,Fabio;Hill,KyleJ;Burke,DonaldH;Lange,MargaretJ;Quinn,ThomasP;Neogi,Ujjwal;Sönnerborg,Anders
- 通讯作者:Sönnerborg,Anders
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donald H Burke其他文献
Donald H Burke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donald H Burke', 18)}}的其他基金
Mechanism of Microbial DNA Hypervariation through Mutagenic Transposition
通过诱变转座导致微生物 DNA 高度变异的机制
- 批准号:
10221727 - 财政年份:2018
- 资助金额:
$ 23.03万 - 项目类别:
Mechanism of Microbial DNA Hypervariation through Mutagenic Transposition
通过诱变转座导致微生物 DNA 高度变异的机制
- 批准号:
9788497 - 财政年份:2018
- 资助金额:
$ 23.03万 - 项目类别:
Mechanism of Microbial DNA Hypervariation through Mutagenic Transposition
通过诱变转座导致微生物 DNA 高度变异的机制
- 批准号:
10387714 - 财政年份:2018
- 资助金额:
$ 23.03万 - 项目类别:
Strain-specific and pan-filoviral aptamer recognition of Ebola virus glycoproteins
埃博拉病毒糖蛋白的菌株特异性和泛丝状病毒适体识别
- 批准号:
9293978 - 财政年份:2016
- 资助金额:
$ 23.03万 - 项目类别:
Strain-specific and pan-filoviral aptamer recognition of Ebola virus glycoproteins
埃博拉病毒糖蛋白的菌株特异性和泛丝状病毒适体识别
- 批准号:
9181298 - 财政年份:2016
- 资助金额:
$ 23.03万 - 项目类别:
EVALUATION OF CANDIDATE VACCINE TECHNOLOGIES USING AGENT BASED COMPUTATIONAL ME
使用基于代理的计算 ME 评估候选疫苗技术
- 批准号:
8171787 - 财政年份:2010
- 资助金额:
$ 23.03万 - 项目类别:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
抗HIV核酸适体效力和耐药性的测定
- 批准号:
7924282 - 财政年份:2009
- 资助金额:
$ 23.03万 - 项目类别:
EVALUATION OF CANDIDATE VACCINE TECHNOLOGIES USING AGENT BASED COMPUTATIONAL ME
使用基于代理的计算 ME 评估候选疫苗技术
- 批准号:
7956315 - 财政年份:2009
- 资助金额:
$ 23.03万 - 项目类别:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
抗HIV核酸适体效力和耐药性的测定
- 批准号:
7879022 - 财政年份:2009
- 资助金额:
$ 23.03万 - 项目类别:
Determinates of anti-HIV nucleic acid aptamer potency and resistance
抗HIV核酸适体效力和耐药性的测定
- 批准号:
7801719 - 财政年份:2009
- 资助金额:
$ 23.03万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
- 批准号:
24K15172 - 财政年份:2024
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
- 批准号:
23K04928 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
- 批准号:
10744934 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
- 批准号:
573688-2022 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10704557 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10537846 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
- 批准号:
2753921 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
- 批准号:
10328140 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
- 批准号:
10621368 - 财政年份:2021
- 资助金额:
$ 23.03万 - 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
- 批准号:
2111821 - 财政年份:2021
- 资助金额:
$ 23.03万 - 项目类别:
Standard Grant














{{item.name}}会员




